You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 15, April 21, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (10)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Renal Diseases
 •Dialysis
 •Lipids and Lipid Disorders
 •Alert me on articles by topic

Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We are concerned that the sample of Dr Liu and colleagues1 may not be representative of US patients who receive dialysis. The median age of patients receiving incident dialysis in the United States is 64.5 years,2 whereas in the study by Liu et al it was 57.2 years for all patients and 53.7 years for those without malnutrition-inflammation complex syndrome (MICS). The renal transplant rate in the US dialysis population is approximately 5.5 per 100 patient-years.2 One would thus expect 103 in the cohort of Liu et al, but this is substantially fewer than the 153 the authors reported. Hence, the younger age and the higher transplant rate in this study indicate a dialysis population that is substantially healthier than average.

The authors stated that their findings support aggressive treatment of hypercholesterolemia in patients receiving dialysis. We disagree with this conclusion, as the authors' own analyses in . . . [Full Text of this Article]

Kamyar Kalantar-Zadeh, MD, PhD, MPH
kamkal@ucla.edu
Harbor-UCLA Medical Center Heart and Lung Institute
Torrance, Calif

Stefan D. Anker, MD, PhD
Imperial College
London, England


RELATED ARTICLES

Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis
Uffe Ravnskov
JAMA. 2004;291(15):1833-1834.
EXTRACT | FULL TEXT  

Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis—Reply
Josef Coresh and Yongmei Liu
JAMA. 2004;291(15):1834-1835.
EXTRACT | FULL TEXT  

Association Between Cholesterol Level and Mortality in Dialysis Patients: Role of Inflammation and Malnutrition
Yongmei Liu, Josef Coresh, Joseph A. Eustace, J. Craig Longenecker, Bernard Jaar, Nancy E. Fink, Russell P. Tracy, Neil R. Powe, and Michael J. Klag
JAMA. 2004;291(4):451-459.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association between Serum Lipids and Survival in Hemodialysis Patients and Impact of Race
Kilpatrick et al.
J. Am. Soc. Nephrol. 2007;18:293-303.
ABSTRACT | FULL TEXT  

The association of lipid levels with mortality in patients on chronic peritoneal dialysis
Habib et al.
Nephrol Dial Transplant 2006;21:2881-2892.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.